Erratum: Cholesterol metabolism in the central nervous system during early development and in the mature animal (Journal of Lipid Research (August 2004) 45 (1375-1397) DOI: 10.1194/jlr.R400004-JLR200);Cholesterol metabolism in the central nervous system during early development and in the mature animal

Journal of Lipid Research

Volumn 45, Issue 8, 2004, Pages 1375-1397

  Dietschy, John M ^a   Turley, Stephen D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Amyloid peptide; Apolipoprotein A I; Apolipoprotein E; ATP binding cassette transporters; Blood brain barrier; Dementia; Lipoprotein transporters; Oxysterols

Indexed keywords

ABC TRANSPORTER; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL DERIVATIVE; CARRIER PROTEIN; CHOLESTEROL;

ALZHEIMER DISEASE; ANIMAL CELL; BASAL METABOLIC RATE; BLOOD BRAIN BARRIER; BRAIN GROWTH; BRAIN MATURATION; BRAIN SIZE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; DEMENTIA; EMBRYO DEVELOPMENT; ENERGY EXPENDITURE; ESTERIFICATION; LIPID BRAIN LEVEL; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEROL METABOLISM; ANIMAL; ANTIBODY SPECIFICITY; CEBIDAE; CELL MEMBRANE; CHICK EMBRYO; CHICKEN; EVOLUTION; HISTOLOGY; HUMAN; METABOLISM; PELVIS; PRENATAL DEVELOPMENT;

ANIMALS; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; CHICK EMBRYO; CHICKENS; CHOLESTEROL; EVOLUTION; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; ORGAN SPECIFICITY; PELVIS; SAIMIRI;

EID: 3543104951     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R400004-JLR200     Document Type: Erratum

References (187)

1. Ellis, G. W., and J. A. Gardner. 1909. The origin and destiny of cholesterol in the animal organism. Part IV. The cholesterol contents of eggs and chicks. Proc. R. Soc. Ser. B. Biol. Sci. 81: 129-132.
2. Dam, H. 1929. Determination of cholesterol by the digitonin method, especially in hen's eggs and in chickens. Biochem. Z. 215: 468-474.
3. Tsuji, F. I., M. Brin, and H. H. Williams. 1955. Lipid phosphorus and cholesterol changes in hen's egg during incubation. Arch. Biochem. Biophys. 56: 290-296.
4. Rittenberg, D., and R. Schoenheimer. 1937. Deuterium as an indicator in the study of intermediary metabolism. XI. Further studies on the biological uptake of deuterium into organic substances, with special reference to fat and cholesterol formation. J. Biol. Chem. 121: 235-253.
5. Connor, W. E., R. Johnston, and D. S. Lin. 1969. Metabolism of cholesterol in the tissues and blood of the chick embryo. J. Lipid Res. 10: 388-394.
6. Golomb, B. A., H. Stattin, and S. Mednick. 2000. Low cholesterol and violent crime. J. Psychiatr. Res. 34: 301-309.
7. Virkkunen, M., and H. Penttinen. 1984. Serum cholesterol in aggressive conduct disorder: a preliminary study. Biol. Psychiatry. 19: 435-439.
8. Golomb, B. A. 1998. Cholesterol and violence: is there a connection? Ann. Intern. Med. 128: 478-487.
9. Sparks, D. L., H. Liu, S. W. Scheff, C. M. Coyne, and J. C. Hunsaker III. 1993. Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J. Neuropathol. Exp. Neurol. 52: 135-142.
10. Sparks, D. L., S. W. Scheff, J. C. Hunsaker III, H. Liu, T. Landers, and D. R. Gross. 1994. Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126: 88-94.
11. Jick, H., G. L. Zornberg, S. S. Jick, S. Seshadri, and D. A. Drachman. 2000. Statins and the risk of dementia. Lancet. 356: 1627-1631.
12. Wolozin, B., W. Kellman, P. Ruosseau, G. G. Celesia, and G. Siegel. 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57: 1439-1443.
13. Michikawa, M. 2003. Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease? J. Neurosci. Res. 72: 141-146.
14. Rubin, L. L., and J. M. Staddon. 1999. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22. 11-28.
15. Panzenboeck, U., Z. Balazs, A. Sovic, A. Hrzenjak, S. Levak-Frank, A. Wintersperger, E. Malle, and W. Sattler. 2002. ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J. Biol. Chem. 277: 42781-42789.
16. Wang, L., G. U. Schuster, K. Hultenby, Q. Zhang, S. Andersson, and J-Å. Gustafsson. 2002. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc. Natl. Acad. Sci. USA. 99: 13878-13883.
17. Whitney, K. D., M. A. Watson, J. L. Collins, W. G. Benson, T. M. Stone, M. J. Numerick, T. K. Tippin, J. G. Wilson, D. A. Winegar, and S. A. Kliewer. 2002. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 16: 1378-1385.
18. Herz, J., and H. H. Bock. 2002. Lipoprotein receptors in the nervous system. Annu. Rev. Biochem. 71: 405-434.
19. Weisgraber, K. H., A. D. Roses, and W. J. Strittmatter. 1994. The role of apolipoprotein E in the nervous system. Curr. Opin. Lipidol. 5: 110-116.
20. Simons, K., and G. van Meer. 1988. Lipid sorting in epithelial cells. Biochemistry. 27: 6197-6202.
21. van Meer, G. 2002. Cell biology. The different hues of lipid rafts. Science. 296: 855-857.
22. Pike, L. J. 2003. Lipid rafts: bringing order to chaos. J. Lipid Res. 4: 655-667.
23. de Groot, B. L., and H. Grübmuller. 2001. Water permeation across biological membranes: mechanism and dynamics of aquaporin-1 and GlpF. Science. 294: 2353-2357.
24. Spady, D. K., and J. M. Dietschy. 1983. Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster and rat. J. Lipid Res. 24: 303-315.
25. Dietschy, J. M., S. D. Turley, and D. K. Spady. 1993. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34: 1637-1659.
26. Goldstein, J. L., S. E. Dana, J. R. Faust, A. L. Beaudet, and M. S. Brown. 1975. Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. J. Biol. Chem. 250: 8487-8495.
27. Ishibashi, S., J. Herz, N. Maeda, J. L. Goldstein, and M. S. Brown. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA. 91: 4431-4435.
28. Loftus, S. K., J. A. Morris, E. D. Carstea, J. Z. Gu, C. Cummings, A. Brown, J. Ellison, K. Ohno, M. A. Rosenfeld, D. A. Tagle, P. G. Pentchev, and W. J. Pavan. 1997. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science. 277: 232-235.
29. Xie, C., S. D. Turley, P. G. Pentchev, and J. M. Dietschy. 1999. Cholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein. Am. J. Physiol. 276: E336-E344.
30. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
31. Landschulz, K. T., R. K. Pathak, A. Rigotti, M. Krieger, and H. H. Hobbs. 1996. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 98: 984-995.
32. Rinninger, F., and R. C. Pittman. 1987. Regulation of the selective uptake of high density lipoprotein-associated cholesteryl esters. J. Lipid Res. 28: 1313-1325.
33. Stangl, H., G. Cao, K. L. Wyne, and H. H. Hobbs. 1998. Scavenger receptor, class B, type I-dependent stimulation of cholesterol esterification by high density lipoproteins, low density lipoproteins, and nonlipoprotein cholesterol. J. Biol. Chem. 273: 31002-31008.
34. Xie, C., S. D. Turley, and J. M. Dietschy. 2000. Centripetal cholesterol flow from the extrahepatic organs through the liver is normal in mice with mutated Niemann-Pick type C protein (NPC1). J. Lipid Res. 41: 1278-1289.
35. Davies, J. P., B. Levy, and Y. A. Ioannou. 2000. Evidence for a Niemann-Pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics. 65: 137-145.
36. Altmann, S. W., H. R. Davis, Jr., L-j. Zhu, X. Yao, L. M. Hoos, G. Tetzloff, S. P. N. Iyer, M. Maguire, A. Golovko, M. Zeng, L. Wang, N. Murgolo, and M. P. Graziano. 2004. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science. 303: 1201-1204.
37. Yokoyama, S. 2000. Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim. Biophys. Acta. 1529: 231-244.
38. Fielding, C. J., and P. E. Fielding. 2001. Cellular cholesterol efflux. Biochim. Biophys. Acta. 1533: 175-189.
39. Yu, L., R. E. Hammer, J. Li-Hawkins, K. von Bergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs. 2002. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA. 99: 16237-16242.
40. Liu, L., A. E. Bortnick, M. Nickel, P. Dhanasekaran, P. V. Subbaiah, S. Lund-Katz, G. H. Rothblat, M. C. Phillips, and S. T. Thuahnai. 2003. Effects of apolipoprotein A-I on ATP-binding cassette transporter AI-mediated efflux of macrophage phospholipid and cholesterol. Formation of nascent high density lipoprotein particles. J. Biol. Chem. 278: 42976-42984.
41. Russell, D. W. 2003. The enzymes, regulation and genetics of bile acid synthesis. Annu. Rev. Biochem. 72: 137-174.
42. Turley, S. D., and J. M. Dietschy. 1981. The contribution of newly synthesized cholesterol to biliary cholesterol in the rat. J. Biol. Chem. 256: 2438-2446.
43. Dietschy, J. M., and S. D. Turley. 2002. Control of cholesterol turnover in the mouse. J. Biol. Chem. 277: 3801-3804.
44. Groen, A. K., R. P. J. O. Elferink, H. J. Verkade, and F. Kuipers. 2004. The ins and outs of reverse cholesterol transport. Trends Mol. Med. 36: 135-145.
45. Yu, L., K. Von Bergmann, D. Lutjohann, H. H. Hobbs, and J. C. Cohen. 2004. Selective sterol accumulation in ABCG5/ABCG8-deficient mice. J. Lipid Res. 45: 301-307.
46. Herz, J. 2001. The LDL receptor gene family: (un) expected signal transducers in the brain. Neuron. 29: 571-581.
47. Borghini, I., F. Barja, D. Pometta, and R. W. James. 1995. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim. Biophys. Acta. 1255: 192-200.
48. Dietschy, J. M., and J. D. Wilson. 1968. Cholesterol synthesis in the squirrel monkey: relative rates of synthesis in various tissues and mechanisms of control. J. Clin. Invest. 47: 166-174.
49. Davison, A. N. 1965. Brain sterol metabolism. Adv. Lipid Res. 3: 171-196.
50. Kabara, J. J. 1973. A critical review of brain cholesterol metabolism. Prog. Brain Res. 40: 363-382.
51. Jurevics, H., and P. Morell. 1995. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64: 895-901.
52. Turley, S. D., D. K. Burns, and J. M. Dietschy. 1998. Preferential utilization of newly synthesized cholesterol for brain growth in neonatal lambs. Am. J. Physiol. 274: E1099-E1105.
53. Quan, G., C. Xie, J. M. Dietschy, and S. D. Turley. 2003. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res. 146: 87-98.
54. Davison, A. N., and M. Wajda. 1962. Cerebral lipids in multiple sclerosis. J. Neurochem. 9: 427-432.
55. Nervi, F. O., H.J. Weis, and J. M. Dietschy. 1975. The kinetic characteristics of inhibition of hepatic cholesterogenesis by lipoproteins of intestinal origin. J. Biol. Chem. 250: 4145-4151.
56. Nervi, F. O., and J. M. Dietschy. 1975. Ability of six different lipoprotein fractions to regulate the rate of hepatic cholesterogenesis in vivo. J. Biol. Chem. 250: 8704-8711.
57. Andersen, J. M., S. D. Turley, and J. M. Dietschy. 1982. Relative rates of sterol synthesis in the liver and various extrahepatic tissues of normal and cholesterol-fed rabbits. Relationship to plasma lipoprotein and tissue cholesterol levels. Biochim. Biophys. Acta. 711: 421-430.
58. Kleiber, M. 1961. Body size and metabolic rate. In The Fire of Life. Ah Introduction to Animal Energetics. John Wiley & Sons, New York. 177-216.
59. Xie, C., E. G. Lund, S. D. Turley, D. W. Russell, and J. M. Dietschy. 2003. Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J. Lipid Res. 44: 1780-1789.
60. Aiello, L. C., and P. Wheeler. 1995. The expensive-tissue hypothesis. The brain and the digestive system in human and primate evolution. Curr. Anthropol. 36: 199-221.
61. Dietschy, J. M., and S. D. Turley. 2001. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12: 105-112.
62. Cavender, C. P., S. D. Turley, and J. M. Dietschy. 1995. Sterol metabolism in fetal, newborn, and suckled lambs and their response to cholesterol after weaning. Am. J. Physiol. 269: E331-E340.
63. Parker, C. R., Jr., B. R. Carr, E. R. Simpson, and P. C. MacDonald. 1983. Decline in the concentration of low-density lipoprotein-cholesterol in human fetal plasma near term. Metabolism. 32: 919-923.
64. Johansson, M. B. N., and B. W. Karlsson. 1982. Lipoprotein and lipid profiles in the blood serum of the fetal, neonatal and adult pig. Biol. Neonate. 42: 127-137.
65. Davis, P. A., and T. M. Forte. 1982. Neonatal umbilical cord blood lipoproteins. Isolation and characterization of intermediate density and low density lipoproteins. Arteriosclerosis 2: 37-43.
66. Grobe-Einsler, R. 1982. Vergleichende Untersuchung über Gallensauren und Cholesterinsynthese im Kleinkindesalter bei gesunden und bei Kindern mit cystischer Fibrose. Universität zu Bonn, Bonn, Germany.
67. Wong, W. W., D. L. Hachey, W. Insull, A. R. Opekun, and P. D. Klein. 1993. Effect of dietary cholesterol on cholesterol synthesis in breast-fed and formula-fed infants. J. Lipid Res. 34: 1403-1411.
68. Cruz, M. L., F. Mimouni, W. Wong, D. L. Hachey, P. Klein, and R. C. Tsang. 1991. Effects of infant nutrition on cholesterol synthesis rates in infancy (Abstract). Clin. Res. 39: 689A.
69. Hayes, K. C., A. Pronczuk, R. A. Wood, and D. G. Guy. 1992. Modulation of infant formula fat profile alters the low-density lipoprotein/high density lipoprotein ratio and plasma fatty acid distribution relative to those with breast-feeding. J. Pediatr. 120 (Suppl.): S109-S116.
70. Cruz, M. L. A., W. W. Wong, F. Mimouni, D. L. Hachey, K. D. R. Setchell, P. D. Klein, and R. C. Tsang. 1994. Effects of infant nutrition on cholesterol synthesis rates. Pediatr. Res. 35: 135-140.
71. Whyte, H. M., and I. L. Yee. 1958. Serum cholesterol levels of Australians and natives of New Guinea from birth to adulthood. Australas. Ann. Med. 7: 336-339.
72. Carroll, K. K., and R. M. G. Hamilton, 1973. Plasma cholesterol levels in suckling and weaned calves, lambs, pigs, and colts. Lipids. 8: 635-640.
73. Méndez, J., C. Tejada, and M. Flores. 1962. Serum lipid levels among rural Guatemalan Indians. Am. J. Clin. Nutr. 10: 403-409.
74. Sinnett, P. F., and H. M. Whyte. 1973. Epidemiological studies in a total highland population, Tukisenta, New Guinea. Cardiovascular disease and relevant clinical, electrocardiographic, radiological and biochemical findings. J. Chronic Dis. 26: 265-290.
75. Connor, W. E., M. T. Cerqueira, R. W. Connor, R. B. Wallace, M. R. Malinow, and H. R. Casdorph. 1978. The plasma lipids, lipoproteins, and diet of the Tarahumara Indians of Mexico. Am. J. Clin. Nutr. 31: 1131-1142.
76. McMurry, M. P., W. E. Connor, D. S. Lin, M. T. Cerqueira, and S. L. Connor. 1985. The absorption of cholesterol and the sterol balance in the Tarahumara Indians of Mexico fed cholesterol-free and high cholesterol diets. Am. J. Clin. Nutr. 41: 1289-1298.
77. Chen, Z., R. Peto, R. Collins, S. MacMahon, J. Lu, and W. Li. 1991. Serum cholesterol concentration and coronary heart disease in populations with low cholesterol concentrations. BMJ. 303: 276-282.
78. McMurry. M. P., M. T. Cerqueira, S. L. Connor, and W. E. Wonnor. 1991. Changes in lipid and lipoprotein levels and body weight in Tarahumara Indians after consumption of an affluent diet. N. Engl. J. Med. 325: 1704-1708.
79. Lewis, L. A., F. Olmsted, I. H. Page, E. Y. Lawry, G. V. Mann, F. J. Stare, M. Hanig, M. A. Lauffer, T. Gordon, and F. E. Moore. 1957. Serum lipid levels in normal persons. Findings of a cooperative study of lipoproteins and atherosclerosis. Circulation. 16: 227-245.
80. Martin, M. J., S. B. Hulley, W. S. Browner, L. H. Kuller, and D. Wentworth. 1986. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men. Lancet. 2: 933-936.
81. Berenson, G. S., W. A. Wattigney, R. E. Tracy, W. P. Newman III, S. R. Srinivasan, L. S. Webber, E. R. Dalferes, Jr., and J. P. Strong. 1992. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am. J. Cardiol. 70: 851-858.
82. Mitchell, B. D., M. P. Stern, S. M. Haffner, H. P. Hazuda, and J. K. Patterson. 1990. Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. Am. J. Epidemiol. 131: 423-433.
83. Salen, G., S. Shefer, A. K. Batta, G. S. Tint, G. Xu, A. Honda, M. Irons, and E. R. Elias. 1996. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. J. Lipid Res. 37: 1169-1180.
84. Lifshitz, F., and N. Moses. 1989. Growth failure. A complication of dietary treatment of hypercholesterolemia. Am. J. Dis. Child. 143: 537-542.
85. Barness, L. A. 1994. Nutritional requirements of infants and children with respect to cholesterol and related compounds. Am. J. Med. Genet. 50: 353-354.
86. Jenkins, C. D., C. G. Hames, S. J. Zyzanski, R. H. Rosenman, and M. Friedman. 1969. Psychological traits and serum lipids. I. Findings from the California Psychological Inventory. Psychosom. Med. 31: 115-128.
87. Engelberg, H. 1992. Low serum cholesterol and suicide. Lancet. 339: 727-729.
88. Hawton, K., P. Cowen, D. Owens, A. Bond, and M. Elliott. 1993. Low serum cholesterol and suicide. Br. J. Psychiatry. 162: 818-825.
89. Kaplan, J. R., K. P. Klein, and S. B. Manuck. 1997. Cholesterol meets Darwin: public health and evolutionary implications of the cholesterol-serotonin hypothesis. Evol. Anthropol. 6: 28-37.
90. Steegmans, P. H., D. Fekkes, A. W. Hoes, A. A. Bak, E. van der Does, and D. E. Grobbee. 1996. Low serum cholesterol concentration and serotonin metabolism in men. BMJ. 312: 221.
91. Peterson, B., E. Trell, and N. H. Sternby. 1981. Low cholesterol level as risk factor for noncoronary death in middle-aged men. J. Am. Med. Assoc. 245: 2056-2057.
92. Muldoon, M. F., S. B. Manuck, and K. A. Matthews. 1990. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 301: 309-314.
93. Jacobs, D. R., Jr. 1993. Why is low blood cholesterol associated with risk of nonatherosclerotic disease death? Annu. Rev. Public Health. 14: 95-114.
94. Iribarren, C., D. M. Reed, R. Chen, K. Yano, and J. H. Dwyer. 1995. Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation. 92: 2396-2403.
95. Evans, R. M., C. L. Emsley, S. Gao, A. Sahota, K. S. Hall, M. R. Farlow, and H. Hendrie. 2000. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology. 54: 240-242.
96. Kivipelto, M., E. L. Helkala, M. P. Laakso, T. Hanninen, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto, and A. Nissinen. 2001. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 322: 1447-1451.
97. Kivipelto, M., E. L. Helkala, T. Hanninen, M. P. Laakso, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto, and A. Nissinen. 2001. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 56: 1683-1689.
98. Howland, D. S., S. P. Trusko, M. J. Savage, A. G. Reaume, D. M. Lang, J. D. Hirsch, N. Maeda, R. Siman, B. D. Greenberg, R. W. Scott, and D. G. Flood. 1998. Modulation of secreted β-amyloid precursor protein and amyloid β-peptide in brain by cholesterol. J. Biol. Chem. 273: 16576-16582.
99. Allman, J. M. 1999. Evolving Brains. Scientific American Library, New York.
100. Koester, J., and S. A. Siegelbaum. 2000. Local signaling: passive electrical properties of the neuron. In Principles of Neural Science. E. R. Kandel, J. H. Schwartz, and T. M. Jessell, editors. Elsevier, New York. 140-149.
101. Gerhart, J., and M. Kirschner. 1997. Myelin and the origin of a new cell type. In Cells, Embryos, and Evolution: Toward a Cellular and Developmental Understanding of Phenotypic Variation and Evolutionary Adaptability. Blackwell Science, Malden, MA. 209-214.
102. Raine, C. S. 1984. Morphology of myelin and myelination. In Myelin. P. Morell, editor. Plenum Press, New York. 1-50.
103. Schwartz, J. H., and G. L. Westbrook. 2000. The cytology of neurons. In Principles of Neural Science. E. R. Kandel, J. H. Schwartz, and T. M.Jessell, editors. Elsevier, New York. 67-87.
104. Waehneldt, T. V. 1990. Phylogeny of myelin proteins. Ann. N. Y. Acad. Sci. 605: 15-28.
105. Norton, W. T., and W. Cammer. 1984. Isolation and characterization of myelin. In Myelin. P. Morell, editor. Plenum Press, New York. 147-195.
106. Snipes, G.J., and U. Suter. 1997. Cholesterol and myelin. In Subcellular Biochemistry. Vol. 28. R. Bittman, editor. Plenum Press, New York. 173-204.
107. Alberts, B., D. Bray, J. Lewis, M. Raff, K. Roberts, and J. D. Watson. 1989. The plasma membrane. In Molecular Biology of the Cell. M. Robertson, editor. Garland Publishing, New York. 275-340.
108. Northcutt, R. G., and J. H. Kaas. 1995. The emergence and evolution of mammalian neocortex. Trends Neurosci. 18: 373-379.
109. Clark, D. A., P. P. Mitra, and S. S-H. Wang. 2001. Scalable architecture in mammalian brains. Nature. 411: 189-193.
110. Zhang, K., and T. J. Sejnowski. 2000. A universal scaling law between gray matter and white matter of cerebral cortex. Proc. Natl. Acad. Sci. USA. 97: 5621-5626.
111. Dobbing, J., and J. Sands. 1970. Growth and development of the brain and spinal cord of the guinea pig. Brain Res. 17: 115-123.
112. Wallin, L. A., C. P. Fawcett, and C. R. Rosenfeld. 1989. Oxytocin stimulates glucagon and insulin secretion in fetal and neonatal sheep. Endocrinology. 125: 2289-2296.
113. Turley, S. D., D. K. Burns, C. R. Rosenfeld, and J. M. Dietschy. 1996. Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep. J. Lipid Res. 37: 1953-1961.
114. Lentner, C. 1981. Geigy Scientific Tables. Vol. 1. Ciba-Geigy Corp., West Caldwell, NJ.
115. Muse, E. D., H. Jurevics, A. D. Toews, G. K. Matsushima, and P. Morell. 2001. Parameters related to lipid metabolism as markers of myelination in mouse brain. J. Neurochem. 76: 77-86.
116. Renkin, E. M. 1977. Multiple pathways of capillary permeability. Circ. Res. 41: 735-743.
117. Stewart, P. A., and E. M. Hayakawa. 1987. Interendothelial junctional changes underlie the developmental 'tightening' of the blood-brain barrier. Dev. Brain Res. 32: 271-281.
118. Wolburg, H., and A. Lippoldt. 2002. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38: 323-337.
119. Laterra, J., R. Keep, A. L. Betz, and G. W. Goldstein. 1999. Blood-brain-cerebrospinal fluid barriers. In Basic Neurochemistry. Molecular, Cellular and Medical Aspects. G.J. Siegel, B. W. Agranoff, R. W. Albers, S. K. Fisher, and M. D. Uhler, editors. Lippincott-Rayen, NewYork. 671-689.
120. Cornford, E. M., L. D. Braun, W. H. Oldendorf, and M. A. Hill. 1982. Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults. Am. J. Physiol. 243: C161-C168.
121. Diamond, J. M., and E. M. Wright. 1969. Biological membranes: the physical basis of ion and nonelectrolyte selectivity. Annu. Rev. Physiol. 31: 581-646.
122. Sherrill, B. C., and J. M. Dietschy. 1975. Permeability characteristics of the adipocyte cell membrane and partitioning characteristics of the adipocyte triglyceride core. J. Membr. Biol. 23: 367-383.
123. Repa, J. J., and D. J. Mangelsdorf. 2000. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16: 459-481.
124. Dehouck, B., L. Fenart, M-P. Dehouck, A. Pierce, G. Torpier, and R. Cecchelli. 1997. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J. Cell Biol. 138: 877-889.
125. Spady, D. K., M. Huettinger, D. W. Bilheimer, and J. M. Dietschy. 1987. Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit. J. Lipid Res. 28: 32-41.
126. Osono, Y., L. A. Woollett, J. Herz, and J. M. Dietschy. 1995. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J. Clin. Invest. 95: 1124-1132.
127. Hofmann, S. L., D. W. Russell, J. L. Goldstein, and M. S. Brown. 1987. mRNA for low density lipoprotein receptor in brain and spinal cord of immature and mature rabbits. Proc. Natl. Acad. Sci. USA. 84: 6312-6316.
128. Hanaka, S., T. Abe, H. Itakura, and A. Matsumoto. 2000. Gene expression related to cholesterol metabolism in mouse brain during development. Brain Dev. 22: 321-326.
129. Dietschy, J. M., T. Kita, K. E. Suckling, J. L. Goldstein, and M. S. Brown. 1983. Cholesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors. J. Lipid Res. 24: 469-480.
130. Xu, G., R. J. Servatius, S. Shefer, G. S. Tint, W. T. O'Brien, A. K. Batta, and G. Salen. 1988. Relationship between abnormal cholesterol synthesis and retarded learning in rats. Metabolism. 47: 878-882.
131. Salen, G., I. Horak, M. Rothkopf, J. L. Cohen, J. Speck, G. S. Tint, V. Shore, B. Dayal, T. Chen, and S. Shefer. 1985. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J. Lipid Res. 26: 1126-1133.
132. Edmond, J., R. A. Korsak, J. W. Morrow, G. Torok-Both, and D. H. Catlin. 1991. Dietary cholesterol and the origin of cholesterol in the brain of developing rats. J. Nutr. 121: 1323-1330.
133. Wilson, J. D. 1970. The measurement of the exchangeable pools of cholesterol in the baboon. J. Clin. Invest. 49: 655-665.
134. Chobanian, A. V., and W. Hollander. 1962. Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol. J. Clin. Invest. 41: 1732-1737.
135. Dietschy, J. M., and J. D. McGarry. 1974. Limitations of acetate as a substrate for measuring cholesterol synthesis in liver. J Biol. Chem. 249: 52-58.
136. 14C-labeled substrates. J. Lipid Res. 20: 740-752.
137. 3H] water. J. Lipid Res. 21: 364-376.
138. Turley, S. D., J. M. Andersen, and J. M. Dietschy. 1981. Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J. Lipid Res. 22: 551-569.
139. Dietschy, J. M., and D. K. Spady. 1984. Measurement of rates of cholesterol synthesis using tritiated water. J. Lipid Res. 25: 1469-1476.
140. Turley, S. D., and J. M. Dietschy. 1997. Regional variation in cholesterol synthesis and low density lipoprotein transport in the brain of the fetus, newborn and adult animal. Nutr. Metab. Cardiovasc. Dis. 7: 195-201.
141. Jurevics, H. A., and P. Morell. 1994. Sources of cholesterol for kidney and nerve during development. J. Lipid Res. 35: 112-120.
142. Jurevics, H., T. W. Bouldin, A. D. Toews, and P. Morell. 1998. Regenerating sciatic nerve does not utilize circulating cholesterol. Nueurochem. Res. 23: 401-406.
143. Fu, Q., J. F. Goodrum, C. Hayes, J. D. Hostettler, A. D. Toews, and P. Morell. 1998. Control of cholesterol biosynthesis in Schwann cells. J. Neurochem. 71: 549-555.
144. 27-steroid 26-hydroxylase activity from bovine brain mitochondria. Biochem. Int. 18: 615-622.
145. Zhang, J., Y. Akwa, M. El-Etr, E-E. Baulieu, and J. Sjövall. 1997. Metabolism of 27-, 25- and 24-hydroxycholesterol in rat glial cells and neurons. Biochem. J. 322: 175-184.
146. Bjòrkhem, I., U. Diczfalusy, and D. Lütjohann. 1999. Removal of cholesterol from extrahepatic sources by oxidative mechanisms. Curr. Opin. Lipidol. 10: 161-165.
147. Russell, D. W. 2000. Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta. 1529: 126-135.
148. Lütjohann, D., O. Breuer, G. Ahlborg, I. Nennesmo, Å. Sidén, U. Diczfalusy, and I. Björkhem. 1996. Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxy-cholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA. 93: 9799-9804.
149. Lund, E. G., C. Xie, T. Kotti, S. D. Turley, J. M. Dietschy, and D. W. Russell. 2003. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 287: 22980-22988.
150. Leoni, V., T. Masterman, P. Patel, S. Meaney, U. Diczfalusy, and I. Björkhem. 2003. Side chain oxidized oxysterols in cerebrospinal fluid and integrity of blood-brain and blood-cerebrospinal fluid barriers. J. Lipid Res. 44: 793-799.
151. Björkhem, I., U. Andersson, E. Ellis, G. Alvelius, L. Ellegård, U. Diczfalusy, J. Sjövall, and K. Einarsson. 2001. From brain to bile. Evidence that conjugation and ωw-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J. Biol. Chem. 276: 37004-37010.
152. Ishibashi, S., M. Schwarz, P. K. Frykman, J. Herz, and D. W. Russell. 1996. Disruption of cholesterol 7α-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J. Biol. Chem. 271: 18017-18023.
153. Lund, E. G., J. M. Guileyardo, and D. W. Russell. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA. 96: 7238-7243.
154. Repa, J. J., E. G. Lund, J. D. Horton, E. Leitersdorf, D. W. Russell, J. M. Dietschy, and S. D. Turley. 2000. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J. Biol. Chem. 275: 39685-39692.
155. Schwarz, M., D. W. Russell, J. M. Dietschy, and S. D. Turley. 1998. Marked reduction in bile acid synthesis in cholesterol 7α-hydroxylase deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J. Lipid Res. 39: 1833-1843.
156. Björkhem, I., D. Lütjohann, O. Breuer, A. Sakinis, and Å. Wennmalm. 1997. Importance of a novel oxidative mechanism for elimination of brain cholesterol. J. Biol. Chem. 272: 30178-30184.
157. Björkhem, I., D. Lütjohann, U. Diczfalusy, L. Ståhle, G. Ahlborg, and J. Wahren. 1998. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39: 1594-1600.
158. Smith, M. E., and L. F. Eng. 1965. The turnover of the lipid components of myelin. J. Am. Oil Chem. Soc. 42: 1013-1018.
159. Xie, C., D. K. Burns, S. D. Turley, and J. M. Dietschy. 2000. Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased. J. Neuropathol. Exp. Neurol. 59: 1106-1117.
160. Reid, P. C., N. Sakashita, S. Sugii, Y. Ohno-Iwashita, Y. Shimada, W. F. Hickey, and T-Y. Chang. 2004. A novel cholesterol stain reveals early neuronal cholesterol accumulation in the Niemann-Pick type C1 mouse brain. J. Lipid Res. 45: 582-591.
161. German, D. C., E. M. Quintero, C. L. Liang, B. Ng, S. Punia, C. Xie, and J. M. Dietschy. 2001. Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease. J. Comp. Neurol. 433: 415-425.
162. German, D. C., E. M. Quintero, C-L. Liang, C. Xie, and J. M. Dietschy. 2001. Degeneration of neurons and glia in the Niemann-Pick C mouse is unrelated to the low-density lipoprotein receptor. Neuroscience. 105: 999-1005.
163. Heverin, M., N. Bogdanovic, D. Lutjohann, T. Bayer, I. Pikuleva, L. Bretillon, U. Diczfalusy, B. Winblad, and I. Bjorkhem. 2004. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 45: 186-193.
164. Bretillon, L., D. Lütjohann, L. Ståhle, T. Widhe, L. Bindl, G. Eggersten, U. Diczfalusy, and I. Björkhem. 2000. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. J. Lipid Res. 41: 840-845.
165. Lütjohann, D., A. Papassotiropoulos, I. Björkhem, S. Locatelli, M. Bagli, R. D. Oehring, U. Schlegel, F. Jessen, M. L. Rao, K. von Bergmann, and R. Heun. 2000. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41: 195-198.
166. Locatelli, S., D. Lütjohann, and K. von Bergmann. 2000. Differences in effects of pravastatin and simvastatin (40 mg/day) on total serum cholesterol, 24s-hydroxycholesterol and 27-hydroxy-cholesterol. Atherosclerosis. 151: 43.
167. Vega, G. L., M. F. Weiner, A. M. Lipton, K. von Bergmann, D. Lütjohann, C. Moore, and D. Svetlik. 2003. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch. Neurol. 60: 510-515.
168. de Chaves, E. I. P., A. E. Rusiñol, D. E. Vance, R. B. Camponot, and J. E. Vance. 1997. Role of lipoproteins in the delivery of lipids to axons during axonal regeneration. J. Biol. Chem. 272: 30766-30773.
169. de Chaves, E. I. P., D. E. Vance, R. B. Campenot, R. S. Kiss, and J. E. Vance. 2000. Uptake of lipoproteins for axonal growth of sympathetic neurons. J. Biol. Chem. 275: 19883-19890.
170. Hayashi, H., R. B. Campenot, D. E. Vance, and J. E. Vance. 2004. Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J. Biol. Chem. 279: 14009-14015.
171. Mauch, D. H., K. Nägler, S. Schumacher, C. Göritz, E-C. Müller, A. Otto, and F. W. Pfrieger. 2001. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 294: 1354-1357.
172. Pfrieger, F. W. 2003. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? Bioessays. 25: 72-78.
173. Hering, H., C. C. Lin, and M. Sheng. 2003. Lipid rafts in the maintenance
174. Kaur, C., A.J. Hao, C. H. Wu, and E. A. Ling. 2001. Origin of microglia. Microsc. Res. Tech. 54: 2-9.
175. Fields, R. D., and B. Stevens-Graham. 2002. New insights into neuron-glia communication. Science. 298: 556-562.
176. Marin-Teva, J. L., I. Dusart, C. Colin, A. Gervais, N. Van Rooijen, and M. Mallat. 2004. Microglia promote the death of developing Purkinje cells. Neuron. 41: 535-547.
177. Fagan, A. M., B. A. Murphy, S. N. Patel, J. F. Kilbridge, W. C. Mobley, G. Bu, and D. M. Holtzman. 1998. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (- / -) mice but impaired clearance of axonal degeneration products following injury. Exp. Neurol. 151: 314-325.
178. Fukumoto, H., A. Deng, M. C. Irizarry, M. L. Fitzgerald, and G. W. Rebeck. 2002. Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels. J. Biol. Chem. 277: 48508-48513.
179. Koldamova, R. P., I. M. Lefterov, M. D. Ikonomovic, J. Skoko, P. I. Lefterov, B. A. Isanski, S. T. DeKosky, and J. S. Lazo. 2003. 22R-Hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid β secretion. J. Biol. Chem. 278: 13244-13256.
180. Liang, Y., S. Lin, T. P. Beyer, Y. Zhang, X. Wu, K. R. Bales, R. B. DeMattos, P. C. May, S. D. Li, X. C. Jiang, P. I. Eacho, G. Cao, and S. M. Paul. 2004. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J. Neurochem. 88: 623-634.
181. Pedersen, T. R., J. Kjekshus, K. Berg, T. Haghfelt, O. Fzærgeman, G. Thorgeirsson, K. Pyörälä, T. Miettinen, L. Wilhelmsen, A. G. Olsson, and H. Wedel. 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 344: 1383-1389.
182. Shepherd, J., S. M. Cobbe, I. Ford, C. G. Isles, A. R. Lorimer, P. W. Macfarlane, J. H. McKillop, and C.J. Packard. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 333: 1301-1307.
183. Sacks, F. M., M. A. Pfeffer, L. A. Moye, J. L. Rouleau, J. D. Rutherford, T. G. Cole, L. Brown, J. W. Warnica, J. M. O. Arnold, C-C. Wun, B. R. Davis, and E. Braunwald. 1996. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. Med. 335: 1001-1009.
184. Downs, J. R., M. Clearfield, S. Weis, E. Whitney, D. R. Shapiro, P. A. Beere, A. Langendorfer, E. A. Stein, W. Kruyer, and A. M. Gotto, Jr. 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. J. Am. Med. Assoc. 279: 1615-1622.
185. Heart Protection Study Collaborative Group. 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360: 7-22.
186. Simons, M., P. Keller, J. Dichgans, and J. B. Schulz. 2001. Cholesterol and Alzheimer's disease: is there a link? Neurology. 57: 1089-1093.
187. Raffai, R. L., and K. H. Weisgraber. 2003. Cholesterol: from heart attacks to Alzheimer's disease. J Lipid Res. 44: 1423-1430.